0.420
0.04 (10.01%)
| Penutupan Terdahulu | 0.382 |
| Buka | 0.390 |
| Jumlah Dagangan | 1,103,304 |
| Purata Dagangan (3B) | 1,458,123 |
| Modal Pasaran | 22,600,666 |
| Harga / Buku (P/B) | 1.74 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 7 Aug 2025 |
| EPS Cair (TTM) | 0.090 |
| Nisbah Semasa (MRQ) | 3.36 |
| Aliran Tunai Operasi (OCF TTM) | -21.82 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -12.51 M |
| Pulangan Atas Aset (ROA TTM) | -124.39% |
| Pulangan Atas Ekuiti (ROE TTM) | -19.56% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | ProMIS Neurosciences Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 3.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -2.5 |
| Purata | 0.75 |
|
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 27.56% |
| % Dimiliki oleh Institusi | 28.80% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Allostery Investments Lp | 30 Jun 2025 | 155,720 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 18.00 (HC Wainwright & Co., 4,185.71%) | Beli |
| Median | 11.50 (2,638.10%) | |
| Rendah | 5.00 (Guggenheim, 1,090.48%) | Beli |
| Purata | 11.50 (2,638.10%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 8.00 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 01 Dec 2025 | 18.00 (4,185.71%) | Beli | 7.00 |
| 21 Nov 2025 | 100.00 (23,709.52%) | Beli | 10.50 | |
| Guggenheim | 18 Nov 2025 | 5.00 (1,090.48%) | Beli | 9.00 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |